TRiCares appoints Ahmed Elmouelhi as President & CEO to lead minimally invasive tricuspid regurgitation treatment development.

TRiCares, a leader in minimally invasive tricuspid regurgitation treatment, appoints Ahmed Elmouelhi as new President & CEO. Elmouelhi brings 20+ years of medical device experience, including LAA therapies at AtriCure. The company aims to bring a transfemoral tricuspid valve replacement system to the market, helping severe regurgitation patients without open-heart surgery. TRiCares has support from European life science venture capital firms.